Dr. Sivaranjani Santosh said that presenting ERZL as a new form of ORSL would violate the regulatory directive and could confuse parents who used to associate ORSL with ORS. Photo: X/@dr_sivaranjani
Hyderabad-based pediatrician Sivaranjani Santosh, whose the eight-year struggle led to a key regulatory shift in ORS labelingis now facing legal trouble after major pharmaceutical companies issued notices accusing her of making false, misleading, disparaging and defamatory remarks about their products.
The development comes after the Food Safety and Standards Authority of India (FSSAI) said in a regulation issued in October 2025 that no food brand may use the term “oral rehydration salts” or “ORS” unless the formulation strictly adheres to the standards recommended by the World Health Organization (WHO).
Published – 22 March 2026 20:56 IST
